News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
866,003 Results
Type
Article (87694)
Company Profile (824)
Press Release (777470)
Multimedia
Podcasts (184)
Webinars (28)
Section
Business (233158)
Career Advice (4142)
Deals (39827)
Drug Delivery (143)
Drug Development (91333)
Employer Resources (203)
FDA (18338)
Job Trends (17414)
News (397646)
Policy (39944)
Tag
Academia (3006)
Academic (2)
Accelerated approval (24)
Adcomms (35)
Allergies (134)
Alliances (56980)
ALS (161)
Alzheimer's disease (1746)
Antibody-drug conjugate (ADC) (294)
Approvals (18421)
Artificial intelligence (566)
Autoimmune disease (123)
Automation (33)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (182)
Biotechnology (487)
Bladder cancer (147)
Brain cancer (59)
Breast cancer (566)
Cancer (4489)
Cardiovascular disease (400)
Career advice (3564)
Career pathing (39)
CAR-T (271)
CDC (58)
Cell therapy (747)
Cervical cancer (34)
Clinical research (76271)
Collaboration (1550)
Company closure (5)
Compensation (1029)
Complete response letters (64)
COVID-19 (2973)
CRISPR (92)
C-suite (712)
Cystic fibrosis (145)
Data (5495)
Decentralized trials (2)
Denatured (67)
Depression (127)
Diabetes (486)
Diagnostics (7150)
Digital health (42)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (266)
Drug pricing (205)
Drug shortages (36)
Duchenne muscular dystrophy (218)
Earnings (99861)
Editorial (59)
Employer branding (25)
Employer resources (173)
Events (134280)
Executive appointments (1008)
FDA (21109)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (7)
Frontotemporal dementia (21)
Funding (1404)
Gene editing (199)
Generative AI (57)
Gene therapy (602)
GLP-1 (1073)
Government (5413)
Grass and pollen (8)
Guidances (378)
Healthcare (20941)
HIV (54)
Huntington's disease (44)
IgA nephropathy (79)
Immunology and inflammation (269)
Immuno-oncology (29)
Indications (69)
Infectious disease (3238)
Inflammatory bowel disease (196)
Inflation Reduction Act (16)
Influenza (110)
Intellectual property (212)
Interviews (816)
IPO (17940)
IRA (59)
Job creations (5198)
Job search strategy (2866)
Kidney cancer (17)
Labor market (88)
Layoffs (651)
Leadership (38)
Legal (10153)
Liver cancer (94)
Longevity (14)
Lung cancer (633)
Lymphoma (324)
Machine learning (37)
Management (66)
Manufacturing (717)
MASH (164)
Medical device (14956)
Medtech (14994)
Mergers & acquisitions (22851)
Metabolic disorders (1263)
Multiple sclerosis (148)
NASH (23)
Neurodegenerative disease (305)
Neuropsychiatric disorders (80)
Neuroscience (2908)
NextGen: Class of 2025 (7703)
Non-profit (5100)
Now hiring (61)
Obesity (601)
Opinion (323)
Ovarian cancer (149)
Pain (181)
Pancreatic cancer (194)
Parkinson's disease (262)
Partnered (33)
Patents (457)
Patient recruitment (380)
Peanut (58)
People (66564)
Pharmaceutical (145)
Pharmacy benefit managers (30)
Phase I (23529)
Phase II (33098)
Phase III (24953)
Pipeline (3603)
Policy (316)
Postmarket research (3554)
Preclinical (10632)
Press Release (72)
Prostate cancer (226)
Psychedelics (52)
Radiopharmaceuticals (284)
Rare diseases (762)
Real estate (7432)
Recruiting (80)
Regulatory (28430)
Reports (65)
Research institute (2712)
Resumes & cover letters (651)
Rett syndrome (22)
RNA editing (16)
RSV (81)
Schizophrenia (145)
Series A (226)
Series B (174)
Service/supplier (30)
Sickle cell disease (90)
Special edition (26)
Spinal muscular atrophy (174)
Sponsored (45)
Startups (4324)
State (2)
Stomach cancer (19)
Supply chain (106)
Tariffs (97)
The Weekly (115)
Vaccines (1090)
Venture capital (76)
Weight loss (422)
Women's health (73)
Worklife (21)
Date
Today (128)
Last 7 days (544)
Last 30 days (3387)
Last 365 days (33380)
2025 (31539)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1288)
Alabama (83)
Alaska (7)
Arizona (322)
Arkansas (14)
Asia (51229)
Australia (9008)
California (10599)
Canada (3110)
China (1009)
Colorado (446)
Connecticut (474)
Delaware (315)
Europe (117818)
Florida (1556)
Georgia (342)
Hawaii (3)
Idaho (68)
Illinois (880)
India (61)
Indiana (509)
Iowa (22)
Japan (362)
Kansas (130)
Kentucky (41)
Louisiana (28)
Maine (81)
Maryland (1384)
Massachusetts (7871)
Michigan (335)
Minnesota (614)
Mississippi (6)
Missouri (131)
Montana (34)
Nebraska (27)
Nevada (115)
New Hampshire (81)
New Jersey (2906)
New Mexico (32)
New York (2844)
North Carolina (1519)
North Dakota (10)
Northern California (4960)
Ohio (322)
Oklahoma (22)
Oregon (52)
Pennsylvania (2162)
Puerto Rico (20)
Rhode Island (47)
South America (1656)
South Carolina (60)
South Dakota (1)
Southern California (4074)
Tennessee (164)
Texas (1659)
United States (38658)
Utah (319)
Vermont (1)
Virginia (268)
Washington D.C. (85)
Washington State (893)
West Virginia (4)
Wisconsin (109)
Wyoming (2)
There are 866,003 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Terray Therapeutics Achieves AI-Enabled Drug Discovery Milestone in Collaboration with Bristol Myers Squibb
Success demonstrates the power of EMMI, Terray’s proprietary AI platform integrated with its rapidly expanding 13B+ target-ligand binding database and highly automated lab
December 4, 2025
·
1 min read
Huntington’s disease
FDA Minutes Confirm Challenging Path Ahead for UniQure’s Huntington’s Gene Therapy
Investor optimism has waned as final minutes from uniQure’s pre-BLA meeting with the FDA convey that data from the company’s Phase I/II studies of AMT-130 are “unlikely” to provide the primary evidence to support a biologics license application.
December 4, 2025
·
2 min read
·
Heather McKenzie
Vaccines
Former CDC, FDA Chiefs Decry Vaccine Policy Changes as ACIP Meeting Begins
Writing in separate editorials in two leading medical journals, former chiefs of federal scientific agencies issued warnings about the changes being proposed to vaccine frameworks by current officials.
December 4, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
Sunbird Bio Presents New Clinical Data Supporting the Accuracy of its Blood-Based Alpha-Synuclein Assay for Parkinson’s Disease Detection
December 4, 2025
·
4 min read
Press Releases
ENDRA’s TAEUS® Liver Matches MRI-PDFF Performance at Key Clinical Thresholds, Positioning Device for MASLD/MASH Trial Use
December 4, 2025
·
7 min read
Press Releases
Redefining Acromegaly Care: First Patient Randomized in Debiopharm’s Phase III OXTEND-03™ Trial of 3-Month Debio 4126 Treatment
December 4, 2025
·
4 min read
Press Releases
Estrella Advances STARLIGHT-1 Trial into Phase II Following Positive DSMB Recommendation
December 4, 2025
·
5 min read
Press Releases
Parse Biosciences Launches Evercode Whole Blood Fixation
December 4, 2025
·
2 min read
Press Releases
Arima Genomics Reports New Data at ASH 2025 Supporting More Complete Rearrangement Profiling in DLBCL With Hi-C Technology Used in Aventa Lymphoma
December 4, 2025
·
4 min read
Press Releases
Twist Bioscience Launches New Plasmid Preps to Enable Nucleic Acid Therapeutics Research
December 4, 2025
·
4 min read
1 of 86,601
Next
